David T. Durack
#133,976
Most Influential Person Now
David T. Durack's AcademicInfluence.com Rankings
David T. Durackmedical Degrees
Medical
#2286
World Rank
#2699
Historical Rank
Cardiology
#204
World Rank
#209
Historical Rank
David T. Durackphilosophy Degrees
Philosophy
#6666
World Rank
#9735
Historical Rank
Logic
#3798
World Rank
#5008
Historical Rank
Download Badge
Medical Philosophy
David T. Durack's Degrees
- Doctorate Medicine Harvard University
Why Is David T. Durack Influential?
(Suggest an Edit or Addition)David T. Durack's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Card (2007) (2635)
- New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. (1994) (2285)
- Prevention of bacterial endocarditis. Recommendations by the American Heart Association. (1990) (1182)
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX (1986) (733)
- Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. (1992) (682)
- Special Report Diagnosis and Therapy of Kawasaki Disease in Children (1993) (492)
- Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA (1993) (490)
- Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. (1995) (489)
- Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations. (1989) (408)
- Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. (1990) (372)
- Prevention of infective endocarditis. (1995) (363)
- Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. (1972) (349)
- Guidelines for the Diagnosis of Rheumatic Fever: Jones Criteria, Updated 1992 Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, American Heart Association (1993) (335)
- Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. (1988) (328)
- Antibiotic tolerance among clinical isolates of bacteria (1986) (324)
- Fever of unknown origin--reexamined and redefined. (1991) (316)
- Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. (1985) (313)
- Opportunistic infections and Kaposi's sarcoma in homosexual men. (1981) (286)
- Chronic cryptococcal meningitis: a new experimental model in rabbits. (1980) (266)
- Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions (1975) (246)
- Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. (1982) (237)
- Apparent failures of endocarditis prophylaxis. Analysis of 52 cases submitted to a national registry. (1983) (224)
- Purification of human eosinophil-derived neurotoxin. (1981) (200)
- Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis (1987) (193)
- Prolonged Zidovudine Therapy in Patients With AIDS and Advanced AIDS-Related Complex (1989) (193)
- Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens. (1973) (188)
- The risk of stroke and death in patients with aortic and mitral valve endocarditis. (2001) (187)
- Experimental bacterial endocarditis. II. Survival of a bacteria in endocardial vegetations. (1972) (185)
- Single and Multiple Pyogenic Liver Abscesses: NATURAL HISTORY, DIAGNOSIS AND TREATMENT, WITH EMPHASIS ON PERCUTANEOUS DRAINAGE (1984) (183)
- Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits (1986) (180)
- Neurotoxicity of human eosinophils. (1979) (178)
- Disseminated infection with rapidly growing mycobacteria. (1993) (177)
- Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. (1984) (175)
- EVIDENCE FOR HUMAN INFECTION WITH AN HTLV III/LAV-LIKE VIRUS IN CENTRAL AFRICA, 1959 (1986) (168)
- Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits. (1973) (162)
- Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group. (1998) (159)
- Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. (1989) (142)
- Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis. (1984) (134)
- International health and internal medicine residency training: the Duke University experience. (1995) (125)
- Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. (1988) (124)
- Prevention of bacterial endocarditis. (1991) (122)
- CELLULAR ANTI-GP120 CYTOLYTIC REACTIVITIES IN HIV-1 SEROPOSITIVE INDIVIDUALS (1988) (117)
- Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci. (1974) (117)
- Antibiotics for Prevention of Endocarditis during Dentistry: Time To Scale Back? (1998) (115)
- Validated Risk Score for Predicting 6‐Month Mortality in Infective Endocarditis (2016) (108)
- The “Incubation Period” of Subacute Bacterial Endocarditis (1977) (106)
- The neuroleptic malignant syndrome. (1982) (105)
- Negative predictive value of the Duke criteria for infective endocarditis. (1996) (105)
- Diagnostic methods current best practices and guidelines for histologic evaluation in infective endocarditis. (2002) (102)
- Value of transthoracic echocardiography in predicting embolic events in active infective endocarditis. Duke Endocarditis Service. (1994) (102)
- Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits. (1985) (102)
- Oral microflora as a cause of endocarditis and other distant site infections. (1999) (89)
- Molecular methods for diagnosis of infective endocarditis. (2002) (87)
- Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis. (1975) (86)
- Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells. (1987) (83)
- Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity. (1986) (83)
- Mitochondrial iron loss from leukemia cells injured by macrophages. A possible mechanism for electron transport chain defects. (1988) (82)
- The cost effectiveness of antiretroviral treatment strategies in resource-limited settings (2007) (73)
- Functional studies on human peritoneal eosinophils (1977) (71)
- Toxoplasmosis of the central nervous system. (1991) (60)
- Intestinal parasites and HIV infection in Tanzanian children with chronic diarrhea (1993) (59)
- The weight of medical knowledge. (1978) (59)
- Protective role of complement in experimental Escherichia coli endocarditis (1977) (56)
- GAY COMPROMISE SYNDROME (1981) (56)
- Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli (1980) (56)
- Effects of cyclosporine in experimental cryptococcal meningitis (1985) (54)
- Deficiency of the fifth component of complement in human subjects. Clinical, genetic and immunologic studies in a large kindred. (1979) (52)
- Isoniazid and reaction to cheese. (1978) (52)
- Clinical presentation of infective endocarditis. (2003) (51)
- Infective endocarditis in obstetric and gynecologic practice. (1986) (49)
- Rhodococcus equi Causing Human Pulmonary Infection: Review of 29 Cases (1991) (48)
- Significance of penicillin tolerance in vivo: prevention of experimental Streptococcus sanguis endocarditis. (1983) (47)
- HEPATITIS B SURFACE ANTIGEN COULD HARBOUR THE INFECTIVE AGENT OF AIDS (1983) (47)
- Current practice in prevention of bacterial endocarditis. (1975) (47)
- Cunninghamella: a newly recognized cause of rhinocerebral mucormycosis. (1983) (45)
- Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis (1983) (44)
- Cryptococcemia (1983) (44)
- Chemotherapy of experimental streptococcal endocarditis (1974) (44)
- Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304 (1989) (44)
- Reversible dementia with idiopathic hypereosinophilic syndrome (1989) (43)
- Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole. (1982) (43)
- Manifestations of human T-lymphotropic virus type I infection. (1988) (42)
- Current issues in prevention of infective endocarditis. (1985) (41)
- Failure of ketoconazole in cryptococcal meningitis. (1982) (39)
- Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus. (1981) (39)
- Diagnosis of infective endocarditis. (1993) (38)
- Effect of immunization on susceptibility to experimental Streptococcus mutans and Streptococcus sanguis endocarditis (1978) (38)
- Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis (1985) (38)
- Treatment of infective endocarditis due to viridans streptococci, This statement was prepared by the ad hoc subcommittee on Treatment of Bacterial endocarditis of the American Heart Association Council on Cardiovascular Disease in the Young. (1981) (36)
- Uptake of itraconazole by alveolar macrophages (1993) (35)
- FAILURE OF "ADEQUATE" PENICILLIN THERAPY TO PREVENT BACTERIAL ENDOCARDITIS AFTER TOOTH EXTRACTION (1974) (35)
- End-of-treatment spinal tap in bacterial meningitis. Is it worthwhile? (1982) (34)
- Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci (1982) (33)
- Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial. (1988) (29)
- Detection, Prevention and Management of Urinary Tract Infections (1980) (28)
- Prevention of bacterial endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Bacterial Endocarditis of the Council on Cardiovascular Diseases in the Young of the American Heart Association. (1985) (28)
- Macrophage-mediated fungistasis: requirement for a macromolecular component in serum. (1986) (26)
- Chemotherapy of experimental streptococcal endocarditis. VI. Prevention of enterococcal endocarditis. (1977) (26)
- Evaluating and optimizing outcomes of surgery for endocarditis. (2003) (26)
- Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity (1988) (25)
- Guidelines for long-term management of patients with Kawasaki disease. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. (1994) (24)
- Treatment of experimental disseminated candidiasis with cilofungin (1989) (23)
- Pharmacokinetics of cefoperazone, moxalactam, cefotaxime, trimethoprim and sulphamethoxazole in experimental meningitis. (1981) (22)
- In vitro sensitivity of Naegleria fowleri to qinghaosu and dihydroqinghaosu. (1987) (21)
- Aspergillus Infection of a Permanent Ventricular Pacing Lead (1984) (21)
- Efficacy of immune therapy in early experimental Naegleria fowleri meningitis (1987) (19)
- Opsonic activity of cerebrospinal fluid in experimental cryptococcal meningitis (1990) (17)
- Influence of agglutinating antibody in experimental cryptococcal meningitis. (1981) (16)
- Comparison of cotrimoxazole, ampicillin, and chloramphenicol in treatment of experimental Haemophilus influenzae type B meningitis (1980) (16)
- Hellenic holocaust: a historical clinico-pathologic conference. (2000) (15)
- Effect of Antibiotics on the Prevention of Experimental Bacteroides fragilis Endocarditis (1978) (15)
- Detection of antibodies to avian leukosis/sarcoma viruses (ALSV) and reticuloendotheliosis viruses (REV) in humans by ELISA. (1995) (14)
- Infection with Rhodococcus equi in AIDS. (1986) (14)
- Leukocyte subpopulations in cerebrospinal fluid of normal rabbits. (1982) (13)
- CRYPTOCOCCOSIS AND THE BASIDIOSPORE (1982) (13)
- Chemotactic activity of cerebrospinal fluid in experimental cryptococcal meningitis. (1985) (12)
- Rus in Urbe (1988) (12)
- Method for the purification of Filobasidiella neoformans basidiospores by flow cytometry. (1982) (12)
- An experimental model for Naegleria fowleri-induced primary amebic meningoencephalitis in rabbits. (1984) (12)
- Experience with trimethoprim-sulfamethoxazole in treatment of infective endocarditis. (1988) (11)
- Pharmacokinetics of N-formimidoyl thienamycin and influence of a renal dipeptidase inhibitor in experimental meningitis. (1983) (11)
- Cutaneous leishmaniasis in rural Costa Rica. (1989) (11)
- Echocardiographic detection and clinical significance of left atrial vegetations in active infective endocarditis. (1989) (10)
- Approach to diagnosis of infective endocarditis. (1998) (9)
- Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. (1984) (9)
- Prevention of bacterial endo carditis (1977) (9)
- Outpatient parenteral antibiotic therapy. Management of serious infections. Part II: Amenable infections and models for delivery. Endocarditis. (1993) (9)
- EARLY ONSET OF DAUNORUBICIN (DAUNOMYCIN) CARDIOTOXICITY (1975) (9)
- Criteria for the Diagnosis of Endocarditis and the Role of Echocardiography (1995) (8)
- Opportunistic infections and Kaposi's sarcoma in homosexual men. (1982) (8)
- Antibiotic tolerance among clinical isolates of bacteria. (1986) (8)
- Trimethoprim-sulfamethoxazole vs. ampicillin in the treatment of experimental meningitis due to Streptococcus pneumoniae. (1982) (7)
- Evaluation of in vitro antifungal activity of LY121019 (1988) (6)
- Penicillin prophylaxis of experimental S. viridans endocarditis. (1972) (6)
- In vitro susceptibility testing of Naegleria fowleri to ketoconazole, BAYn7133, and allopurinol riboside. (1984) (6)
- The 1976 Paul B. Beeson lecture. Some observations on experimental endocarditis. (1977) (6)
- Prevention of central nervous system infections in patients at risk. (1984) (5)
- Helminthic infections of the central nervous system. (1991) (5)
- An experimental model for pyogenic liver abscess. (1984) (5)
- In vitro efficacy of cefoperazone compared with cefotaxime, LY127935, and thienamycin. (1980) (4)
- Electrophysiological studies in the Rottnest quokka with nutritional myopathy. (1969) (4)
- Rus in urbe: spotted fever comes to town. (1988) (3)
- Computed tomographic evaluation of an experimental model for pyogenic liver abscesses. (1984) (3)
- Home intravenous antibiotic therapy. (1993) (3)
- Failure of prophylaxis for bacterial endocarditis: American Heart Association registry. (1979) (3)
- The incidence of infective endocarditis following surgical repair of a major congenital defect varied by type of heart defect. (1998) (3)
- Experimental anaerobic liver abscess: observations on treatment. (2008) (3)
- Chronic obstructive pulmonary disease : Mortality and mortality reduction. Discussion (1996) (2)
- Diagnosis and Management of Infective Endocarditis (2007) (2)
- Potential Value of Cefoperazone in Bacterial Meningitis: Experimental Studies (2012) (2)
- SINGLE AND MULTIPLE PYOGENIC ABSCESSES (1984) (2)
- Macrophage oxidation of L-arginine is linked to fungistatic capability. (1990) (2)
- Behcet's syndrome and venous thrombosis. (1973) (2)
- Failure of prophylaxis for bacterial endocarditis: American Heart Association Registry. (1980) (2)
- Infective endocarditis. (1994) (2)
- Letter: Early onset of daunorubicin (daunomycin) cardiotoxicity. (1975) (2)
- Letter: Failure of "adequate" penicillin therapy to prevent bacterial endocarditis after tooth extraction. (1974) (2)
- AN EXPERIMENTAL MODEL FOR NAEGLERIA FOWLERI-INDUCED (1984) (1)
- Failure of prophylaxis for bacterial endocarditis: American Heart Association Registry. (1980) (1)
- Chapter 48 – Fungal Infections of the Central Nervous System (2008) (1)
- Fostering Partnerships between Industry and the Clinical Microbiology Laboratory (2011) (1)
- Fungal pneumonia in the immunocompromised host. (1986) (1)
- Prevention of rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the young, the American Heart Association. (1989) (1)
- Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000–2012) (2023) (1)
- The acquired immune deficiency syndrome. (1984) (1)
- 85 – Prophylaxis of Infective Endocarditis (2015) (1)
- The myocardial lesions in the Rottnest quokka with nutritional myopathy. (1968) (0)
- Failure of prophylaxis for bacterial endocarditis: American Heart Association Registry. (1980) (0)
- Use of third-generation cephalosporins. Streptococci. (1991) (0)
- Letter: Chemoprophylaxis of bacterial endocarditis. (1975) (0)
- Pathophysiology and treatment of hepatitis C. Discussion (1996) (0)
- Failure of prophylaxis for bacterial endocarditis: American Heart Association registry. (1980) (0)
- Letters to the Journal. (1903) (0)
- Failure of prophylaxis for bacterial endocarditis: American Heart Association Registry. (1980) (0)
- Endocarditis: Getting to the Heart of the Matter (2000) (0)
- Cortisone, cyclosporine and cellular immunity in the central nervous system (1987) (0)
- TOLERANCE AND PREVENTION OF EXPERIMENTAL STREPTOCOCCAL ENDOCARDITIS (1983) (0)
- Meningitis in a young infant (2004) (0)
- Macrophage oxidation of smallcap˜L-arginine is linked to fungistatic capability. (1990) (0)
- Ethical issues in infectious diseases. (1994) (0)
- Current practice inprevention ofbacterial endocarditis (1973) (0)
- TOLERANCE IN VIRIDANS STREPTOCOCCI EXERTS A MAJOR INFLUENCE ON EFFICACY OF PENICILLIN INVIVO (1982) (0)
- Chemotherapy ofexperimental streptococcal (1974) (0)
- LackofInVivoandInVitro Bactericidal Activity ofN- Formimidoyl Thienamycin Against Enterococci (1982) (0)
- Protozoal infections of the central nervous system. (1991) (0)
- Important announcement from the American Heart Association. (1979) (0)
- Viral Blisters (1983) (0)
- Failure of prophylaxis for bacterial endocarditis: American Heart Association registry. (1980) (0)
- Dispositif d'auto-injection (2009) (0)
- The 2023 Duke-ISCVID Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. (2023) (0)
- and the Quality of Care and Cardiovascular Disease in the Young, the on Clinical Cardiology, Endocarditis, and on Association. A Guideline From the American Heart Association Rheumatic Prevention of Infective Endocarditis. Guidelines From the American Heart (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David T. Durack?
David T. Durack is affiliated with the following schools:
